GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Subscribe to MindMatters

Celebrating ABTA President and CEO Ralph DeVitto’s Transformative Leadership

ABTA President and CEO Ralph DeVitto is retiring February 2025, after serving the ABTA for seven years. His legacy highlights remarkable achievements, including significantly increasing the organization’s revenue resulting in a substantial boost in research funding and patient resources dedicated to combating brain tumors. Ralph strengthened the ABTA’s mission and broadened its reach to support countless patients, caregivers, families, researchers and stakeholders in the brain tumor community.

We share our deepest gratitude to Ralph for his transformative leadership, integrity, and unwavering commitment in the fight against brain tumors.

Watch his impact through the years!

Make a Difference TOday

Your generosity fuels progress. The American Brain Tumor Association has already invested over $35 million in life-changing brain tumor research, leading to breakthroughs like the FDA approval of vorasidenib, a groundbreaking treatment for low-grade glioma.

Through our Meet Hope Head On campaign, we’re not just funding critical research—we’re also providing free resources and support to patients and caregivers navigating the challenges of a brain tumor diagnosis.

🤍 Join us in bringing hope and advancing care. Donate now.